NL-OMON23616尚未招募不适用
Comparison of 68Ga-PSMA PET/CT with 18F-FDHT PET/CT for re-staging patients with recurrent prostate cancer after radiotherapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
not applicable
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion criteria
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
排除标准
- •- Active cancer besides prostate cancer
- •- Suspected metastases
研究者
相似试验
已完成
不适用
18F-FDG and 68Ga-FAPI PET/CT in Lung AdenocarcinomaLung Adenocarcinoma18F-FDG68Ga-FAPIPET/CTNCT04588064The First Affiliated Hospital of Xiamen University63
进行中（未招募）
1 期
Comparative study of a specific imaging biomarker, 68Ga-PSMA-11, and the standard imaging protocol with 18F-Fluorocholine in the detection of Recurrence in Prostate Cancer PatientsMedDRA version: 20.0 Level: PT Classification code 10036911 Term: Prostate cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10066489 Term: Progression of prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10036917 Term: Prostate cancer stage I System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10036918 Term: Prostate cancer stage II System Organ Class: 10029104 - Neoplasms benign, malignant and unspProstate CancerEUCTR2016-003740-36-PTICNAS Produção Lda.46
Unknown
不适用
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast CarcinomaBreast NeoplasmsPositron Emission TomographyFibroblast Activation Protein InhibitorFluorodeoxyglucose F18NCT05339113The National Center of Oncology, Azerbaijan100
招募中
不适用
Prospective cross-sectional study of 68Ga-PSMA PET/CT in addition to mpMRI in men undergoing 12-month confirmatory biopsy during Active Surveillance for low- or intermediate-risk prostate cancerCancer - ProstateProstate CancerACTRN12622000188730St. Vincent's Prostate Cancer Research Centre225
已完成
不适用
The role of 18F-FDG PET/CT scan compared to CT-scan alone for lymph node staging before radical cystectomyBladder cancerJPRN-UMIN000043722Al Zahraa Hospital300